Sponsors today have more tools than ever to support clinical trial recruitment strategies. Digital campaigns can reach highly specific audiences. Social platforms increase visibility. Hybrid models reduce participation burden and expand geographic flexibility.
Yet patient recruitment remains one of the main obstacles to clinical trial success, causing missed deadlines and increased costs.
The issue is rarely a lack of effort. More often, it’s a lack of connection — specifically, connection to the clinical environments where patients already receive care and make treatment decisions.
This is where local healthcare partnerships make a meaningful difference when conducting clinical trials.
Consider two scenarios:
In the first, a patient comes across information about a clinical trial online. They take time to read through the details and thoughtfully consider whether it may apply to them. Naturally, questions arise: How would this fit into my current care plan? Is this the right next step for me? Who would oversee my treatment?
In the second scenario, that same patient learns about a clinical trial during a routine visit with a physician they’ve trusted for years. The physician explains why the clinical study may be appropriate, how it aligns with the patient’s diagnosis, and what trial participation would involve. Questions are addressed immediately, within the context of an established medical relationship.
The difference between those conversations is significant.
Local healthcare partnerships allow clinical trial opportunities to be introduced as part of ongoing care, rather than as something separate from it. When research sites collaborate with primary care providers, specialty practices, and community clinics, research becomes integrated into the healthcare ecosystem that patients already rely on.
That integration strengthens recruitment in several important ways. Physician referrals are grounded in clinical judgment. Providers understand a patient’s medical history, disease progression, and treatment preferences. When they introduce a study, it is presented as a potential therapeutic option.
This approach fosters informed decision-making and supports patient confidence from the outset.
For sponsors, it means enrollment that is both thoughtful and aligned.
Local healthcare partnerships also broaden access by ensuring that individuals who may benefit from medical research are informed about appropriate study opportunities through their existing care teams.
When research sites are embedded within provider networks, they gain visibility into patient populations actively being treated for specific conditions. That visibility is especially valuable in:
In these settings, healthcare providers can identify individuals who meet eligibility criteria and determine whether a study aligns with their care goals.
Rather than relying solely on broad outreach and self-reported interest, recruiting eligible participants becomes clinically informed. Conversations are personalized, and participation is considered within the broader treatment landscape.
This approach often results in more precise screening and more predictable enrollment progression, while preserving the patient’s role as an active decision-maker.
The ability to cultivate and sustain these partnerships is one of the defining strengths of independent clinical trial sites.
Independent sites are often deeply embedded within their communities. They build long-term relationships with area physicians. They participate in regional healthcare conversations. They remain visible and accessible beyond the lifespan of a single protocol.
At Remington-Davis, that integration extends both outward and inward.
We collaborate with regional provider networks in the Columbus area, so research opportunities are introduced within trusted care settings.
At the same time, our own physician investigators maintain active clinical practices that connect care and research.
For example, our gastroenterology investigator, Dr. Krishna Rayapudi, maintains an active practice six miles from our research facility in Hilliard, Ohio. His ongoing care of patients across a broad spectrum of GI conditions creates organic opportunities to discuss relevant study options during routine visits.
Similarly, Dr. Kevin Schroeder, MD, our nephrologist and principal investigator, is part of a 19-provider nephrology group. That expansive clinical footprint allows appropriate renal study opportunities to be considered within the context of ongoing specialty care.
Beyond partnerships, independent sites offer structural advantages that further support recruitment success:
This agility matters when timelines shift or enrollment targets require recalibration.
Database size and advertising reach are important metrics. But they do not tell the full story.
Sustainable recruitment performance depends on relationships — between sites and providers, between physicians and patients, and between research teams and the communities they serve.
Local healthcare partnerships transform recruitment from outreach into integration. They allow research to be presented as a thoughtful extension of care.
Clinical trial recruitment strategies will continue to evolve alongside technology, while the value of trusted local relationships remains constant.
At Remington-Davis in Columbus, Ohio, our healthcare partnerships — combined with our agility and patient-centric approach — reinforce every recruitment effort we deploy to support successful trial outcomes.
If you’re planning your next study and seeking a site partner who can accelerate your study's start-up, we'd love the chance to connect.
Patient education is essential. When potential clinical trial participants clearly understand the purpose of the study, the time commitment involved, and how the trial fits into their care plan, they are more likely to make informed decisions and remain engaged. Transparent communication early in the recruitment process often improves both enrollment quality and patient retention.
Reducing screen failures starts with thoughtful pre-screening. Recruitment efforts that involve clinically informed referrals, detailed eligibility discussions, and realistic expectation-setting help ensure that patients entering formal screening are more likely to qualify. This improves efficiency and reduces unnecessary burden on participants.
Patient advocacy groups support clinical trial recruitment strategies by increasing disease awareness and educating patients about research opportunities. Because they serve as trusted resources within specific condition communities, they can help foster informed interest in relevant studies. Their role is primarily educational and credibility-building rather than operational enrollment execution.
Patient recruitment companies are often valuable when a study requires rapid enrollment acceleration, national reach, or support across multiple underperforming sites. However, when a research site already has strong local healthcare partnerships, active physician referral networks, and a well-maintained patient database, sponsors may be able to meet enrollment goals without the added cost of external recruitment vendors.
Retention is strengthened by consistent communication, flexible scheduling, responsive study teams, and minimizing logistical burdens. Sites that provide individualized support and maintain regular touchpoints with participants often see higher completion rates when it comes to research participation.
Sponsors may consider reviewing historical retention rates, communication practices, patient satisfaction measures, and how the site handles missed visits or protocol adjustments. A proactive approach to patient engagement often signals stronger long-term study performance.